SML1044
佐奎达 盐酸盐
≥98% (HPLC), powder, p-Glycoprotein inhibitor
别名:
LY-335979, RS-33295-198, （2R）-抗-5- [3- [4-（10,11-二氟亚甲基二苯并亚苄基-5-基）哌嗪-1-基] -2-羟基丙氧基]喹啉 盐酸盐
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C32H31F2N3O2 · xHCl
化学文摘社编号:
分子量:
527.60 (free base basis)
UNSPSC Code:
12161501
PubChem Substance ID:
NACRES:
NA.77
产品名称
佐奎达 盐酸盐, ≥98% (HPLC)
SMILES string
O[C@@H](COC1=C(C=CC=N2)C2=CC=C1)CN(CC3)CCN3[C@@H]4C5=C(C=CC=C5)[C@@H]6[C@@H](C6(F)F)C7=C4C=CC=C7.Cl
InChI
1S/C32H31F2N3O2.ClH/c33-32(34)29-22-7-1-3-9-24(22)31(25-10-4-2-8-23(25)30(29)32)37-17-15-36(16-18-37)19-21(38)20-39-28-13-5-12-27-26(28)11-6-14-35-27;/h1-14,21,29-31,38H,15-20H2;1H/t21-,29-,30+,31-;/m1./s1
InChI key
VQJFFWJUYDGTQZ-FCNWNIDBSA-N
assay
≥98% (HPLC)
form
powder
storage condition
desiccated
color
white to beige
solubility
H2O: 4 mg/mL, clear (warmed)
storage temp.
−20°C
Quality Level
Biochem/physiol Actions
Zosuqidar是一种P-糖蛋白（P-gp，MDR1）的有效抑制剂，P-糖蛋白是一种转运蛋白，是细胞药物外排的一种关键调节剂。
Zosuqidar是一种P-糖蛋白（P-gp，MDR1）的有效抑制剂，P-糖蛋白是一种转运蛋白，是细胞药物外排的一种关键调节剂。 Zosuquidar可使AML和其他癌细胞系对细胞毒性药物敏感。
Features and Benefits
该化合物是ADME Tox研究推荐产品。点击此处 ，查看更多ADME Tox精选产品。想要了解有关生物活性小分子在其他研究领域应用的更多信息，请访问 sigma.com/discover-bsm。
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Yoko Nagaya et al.
Drug metabolism and disposition: the biological fate of chemicals, 48(11), 1183-1190 (2020-08-31)
Estimation of unbound drug concentration in the brain (Cu,brain) is an essential part of central nervous system (CNS) drug development. As a surrogate for Cu,brain in humans and nonhuman primates, drug concentration in cerebrospinal fluid (CCSF) collected by lumbar puncture
J Vérité et al.
Journal of neuroinflammation, 15(1), 182-182 (2018-06-15)
Alzheimer's disease is widely described since the discovery of histopathological lesions in Mrs. Auguste Deter in 1906. However to date, there is no effective treatment to deal with the many cellular and molecular alterations. The complexity is even higher with
Kamil Nosol et al.
Proceedings of the National Academy of Sciences of the United States of America, 117(42), 26245-26253 (2020-10-07)
ABCB1 detoxifies cells by exporting diverse xenobiotic compounds, thereby limiting drug disposition and contributing to multidrug resistance in cancer cells. Multiple small-molecule inhibitors and inhibitory antibodies have been developed for therapeutic applications, but the structural basis of their activity is
Shehab Eid et al.
International journal of molecular sciences, 23(23) (2022-12-12)
Several strands of investigation have established that a reduction in the levels of the cellular prion protein (PrPC) is a promising avenue for the treatment of prion diseases. We recently described an indirect approach for reducing PrPC levels that targets
Nienke R Wevers et al.
Fluids and barriers of the CNS, 18(1), 59-59 (2021-12-16)
In ischemic stroke, the function of the cerebral vasculature is impaired. This vascular structure is formed by the so-called neurovascular unit (NVU). A better understanding of the mechanisms involved in NVU dysfunction and recovery may lead to new insights for
商品
Discover Bioactive Small Molecules for ADME/Tox
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持